Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/20/2005WO2005097987A1 Antiinfection vaccine antigen for mucosa-directional human papillomavirus group
10/20/2005WO2005097982A2 Pufa-pks genes from ulkenia
10/20/2005WO2005097981A2 Novel herpes simplex viruses
10/20/2005WO2005097828A2 Peptides of cav2.2 that inhibit pain
10/20/2005WO2005097824A2 Cytokinin oxidase sequences and methods of use
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005097207A2 Rna interference modulators of hedgehog signaling and uses thereof
10/20/2005WO2005097205A2 Dna virus microrna and methods for inhibiting same
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097171A1 Antiobesity drug
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005WO2005096810A1 Nonhuman transgenic animal as type 2 diabetes model
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005WO2005096805A2 Cambium/xylem-preferred promoters and uses thereof
10/20/2005WO2005096804A2 Self-processing plants and plant parts
10/20/2005WO2005096781A2 Methods and compositions for treating gain-of-function disorders using rna interference
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005096693A2 Cancer prognosis and/or diagnosis method
10/20/2005WO2005083083A3 Materials and methods for treatment of allergic disease
10/20/2005WO2005078122A3 Method for enrichment involving elimination by mismatch hybridisation
10/20/2005WO2005078077A3 Acid alpha-glucosidase and fragments thereof
10/20/2005WO2005063995A3 Sugar and lipid metabolism regulators in plants vi
10/20/2005WO2005062867A3 Novel carotenoids ketolases
10/20/2005WO2005058019A3 Generation of plants with altered oil content
10/20/2005WO2005057176A3 Method for identification of enzymes
10/20/2005WO2005056583A3 Plant virus
10/20/2005WO2005049844A3 Vectors, mutant viruses and methods for generating mutant viruses
10/20/2005WO2005049646A3 “seedy1” nuceic acids for making plants having changed growth characteristics
10/20/2005WO2005040180A3 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression
10/20/2005WO2005037229A3 Methods and compositions for modulating gamete adhesion
10/20/2005WO2005035760A3 Molecular nanomotor
10/20/2005WO2005033694A3 Novel antisense oligomers and use thereof
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005028505A3 Multiepitope polypeptides for cancer immunotherapy
10/20/2005WO2005019267A3 Tie1-binding ligands
10/20/2005WO2005010142A8 Plant centromere compositions
10/20/2005WO2005005603A3 Method for inducing an immune response to cancer antigen
10/20/2005WO2004113528A3 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs
10/20/2005WO2004112575A3 Gene amplification and overexpression in cancer
10/20/2005WO2004103389A3 Means for preventing and treating cellular death and their biological applications
10/20/2005WO2004090103A3 Identification of novel nogo-receptors and methods related thereto
10/20/2005WO2004085613A3 Electrocompetent host cells
10/20/2005WO2004072224A9 Detection of ochratoxin a producing fungi
10/20/2005WO2004007684A3 Synthetic tag genes
10/20/2005WO2003074668A3 Models of cellular development using homozygous stem cells
10/20/2005WO2003000863A3 Defensin polynucleotides and methods of use
10/20/2005US20050235383 Canola line 45H24
10/20/2005US20050235382 Plant regulatory sequences for selective control of gene expression
10/20/2005US20050235381 Environmental stress-tolerant plants
10/20/2005US20050235380 Acquired resistance genes in plants
10/20/2005US20050235379 Development of controlled total vegetative growth for prevention of transgene escape from genetically modified plants and for enhancing biomass production
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050235377 Stress tolerant plants and methods thereof
10/20/2005US20050235376 Method for producing a transgenic plant having modified transport of substances
10/20/2005US20050235375 Transcription factors of cereals
10/20/2005US20050235372 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050235370 Spatiotemporally controlled adult somatic mutagenesis system
10/20/2005US20050235369 Gene regulation II
10/20/2005US20050235368 Method of transporting transgenic Xenopus laeves oocytes
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050235366 A transgenic mouse whose genome comprises a transgene encoding metabotropic glutamate receptor 1 (Grm1) operably linked to the melanocyte-specific promoter expresses the Grm 1 in melanocytes, develops lesions on hairless skin, and lacks pigmentation; screening anticarcinogenic agents; medical diagonosis
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234654 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value
10/20/2005US20050234653 Systems and computer software products for gene expression analysis
10/20/2005US20050234232 Novel compositions for the delivery of negatively charged molecules
10/20/2005US20050234230 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/20/2005US20050234225 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
10/20/2005US20050234223 Drug candidate compounds such as H3 receptor inverse agonists can be screened more easily and efficiently
10/20/2005US20050234221 genetic vectors, host cells and nucleotide sequences that code polypeptides, agonists and antagonists, that preferentially bind to interleukins, used for diagnosis oro prophylaxis of diseases
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234005 Cloning and expression of the full length 110 KDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus
10/20/2005US20050234003 Method of using nucleic acid compositions for muting expression of a gene in animals
10/20/2005US20050234002 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
10/20/2005US20050234001 Methods and compositions for modulating gluconeogenesis using PGC-1
10/20/2005US20050234000 SiRNA delivery into mammalian nerve cells
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233998 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; use in therapeutic, diagnostic, target validation, and genomic discovery
10/20/2005US20050233997 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233996 RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233994 Methods and vectors for expressing siRNA
10/20/2005US20050233993 Methods for promoting homologous recombination
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233991 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
10/20/2005US20050233990 Anti-cancer agents comprising disintegrin genes and the treating methods
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233955 Stimulation of nerve cell regeneration
10/20/2005US20050233458 Novel expansin polynucleotides, related polypeptides and methods of use
10/20/2005US20050233457 Recombining viral vectors for the tetracycline-regulated expression of genes
10/20/2005US20050233456 Retroviral vector; a nucleotide sequence encoding a fusion polypeptide with a C-terminal domain of an intein, a random peptide, an N-terminal domain of an intein;fusion protein is capable of undergoing a reaction to produce a cyclic peptide in a mammalian cell
10/20/2005US20050233455 Acyclic linker-containing oligonucleotides and uses thereof
10/20/2005US20050233452 Cell populations which co-express CD49c and CD90
10/20/2005US20050233448 Apparatus comprising gas permeable membrane/scaffolds for use in cell propagation and enhancing progenitor cell recovery; bioreactors
10/20/2005US20050233431 Antibiotics; thioesterases; host cells
10/20/2005US20050233422 Rapid and enzymeless cloning of nucleic acid fragments
10/20/2005US20050233421 Fed-batch fermentation process and culture medium for the production of plasmid DNA in E. coli on a manufacturing scale
10/20/2005US20050233420 Method for producing cytosine nucleoside compounds
10/20/2005US20050233419 Cleaving chondroitin sulfate with a modified chondroitinase B having the amino acid sequence of the mature peptide; modifying with individual residues involved in substrate binding and catalysis
1 ... 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 ... 4023